A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers [Corrigendum]
Safa M, Natalizio A, Hee CK. Clin Cosmet Investig Dermatol. 2022;15:411-426. The authors have advised there is an error in Table 2 on page 417. The value “0.3 (1.3)” in the Probe S hydration rate: A.U. (SEM) row for Moisturemeter®, Month 1, VYC-12L column should read &...
Saved in:
Main Authors: | Safa M (Author), Natalizio A (Author), Hee CK (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers
by: Safa M, et al.
Published: (2022) -
VYC-12 Injectable Gel Is Safe And Effective For Improvement Of Facial Skin Topography: A Prospective Study
by: Niforos F, et al.
Published: (2019) -
Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines
by: Ogilvie P, et al.
Published: (2020) -
Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
by: Yingzi Cui, et al.
Published: (2022) -
Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
by: Ying Wang, et al.
Published: (2023)